Quantum Biopharma (QNTM) Change in Cash (2019 - 2026)

Quantum Biopharma has disclosed Change in Cash across 7 years of filings, most recently posting $2.4 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $2.4 million, up 198.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $823595.0 (up 112.72% YoY), and the FY2025 annual result was -$4.1 million, down 226.3% from the prior year.
• Change in Cash came in at $2.4 million for Q1 2026 at Quantum Biopharma, up from $1.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $2.9 million in Q4 2024 to a low of -$6.7 million in Q1 2022.
• The 4-year median for Change in Cash is -$619023.5 (2024), against an average of -$706436.8.
• Across the five-year window, Change in Cash slumped 464.13% in 2025 and soared 198.34% in 2026, its largest moves.
• Quantum Biopharma's Change in Cash stood at -$6.7 million in 2022, then soared by 143.01% to $2.9 million in 2024, then sank by 49.25% to $1.5 million in 2025, then jumped by 66.95% to $2.4 million in 2026.
• The last three Change in Cash figures came in at $2.4 million (Q1 2026), $1.5 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.